SCHEMBL4359370

SCHEMBL4359370

N=C(N)Nc1ccc(C(=O)NC(=O)CNC(=O)[C@@H](CO)NS(=O)(=O)Cc2ccc(Cl)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 10/20 0.38
F10 P00742 10/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
TMPRSS11D O60235 1/20 0.36
PLG P00747 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP13 P45452 1/20 0.36
FPR2 P25090 1/20 0.36
POLB P06746 2/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308627 1.00 F2 (0.38) F2F10PRSS1PRSS2PRSS3
Hydrochloric Acid SCHEMBL308853 0.99 F10 (0.37) F2F10PRSS1PRSS2PRSS3
SCHEMBL5499067 0.91 F10 (0.42) F2F10PRSS1PRSS2PRSS3
Hydrochloric Acid SCHEMBL6544447 0.90 F10 (0.42) F2F10PRSS1PRSS2PRSS3
SCHEMBL5494187 0.90 F7 (0.46) F2F10PRSS1PRSS2PRSS3
Hydrochloric Acid SCHEMBL307960 0.89 F7 (0.45) F2F10PRSS1PRSS2PRSS3
SCHEMBL13283064 0.88 CA12 (0.47) F2F10PRSS1PRSS2PRSS3
SCHEMBL5500303 0.82 KMT2A (0.40) F10POLBMAPTMEN1KMT2A
SCHEMBL5502070 0.82 ITGB3 (0.41) F2F10CA1CA2CA9
SCHEMBL2167336 0.81 TMPRSS11D (0.51) F2F10PRSS1TMPRSS11DPLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286837-A1 Oxadiazole compounds as urokinase inhibitors WILEX AG (DE) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286837-A1 Oxadiazole compounds as urokinase inhibitors PLAUR, PLAU, PLAT F2 129/4885F10 512/4885PRSS1 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.